Baidu
map

ADA 2014:良好血糖控制有助于降低心血管事件(CREDIT研究)

2014-07-07 佚名 丁香园

一项新的真实世界研究发现,2型糖尿病患者接受胰岛素治疗后,良好的血糖控制可以减少中期内主要心血管不良事件(MACE)。研究第一作者、伦敦大学学院临床流行病学和生物统计学教授Nick Freemantle说,“过去数年来,诸如ACCORD研究和ADVANCE研究等临床试验为我们带来了一些矛盾信息,而本观察性研究则基于临床实践——发现血糖控制与心血管结局有非常强的关系”。该研究结果来自2型糖尿病患者胰

一项新的真实世界研究发现,2型糖尿病患者接受胰岛素治疗后,良好的血糖控制可以减少中期内主要心血管不良事件(MACE)。

研究第一作者、伦敦大学学院临床流行病学和生物统计学教授Nick Freemantle说,“过去数年来,诸如ACCORD研究和ADVANCE研究等临床试验为我们带来了一些矛盾信息,而本观察性研究则基于临床实践——发现血糖控制与心血管结局有非常强的关系”。

该研究结果来自2型糖尿病患者胰岛素治疗心血管风险评估(CREDIT)研究,由Freemantle教授在美国糖尿病协会2014年科学会议上以海报的形式展示。研究者观察了近3000名糖尿病病史约9年且开始接受胰岛素治疗的患者,这些患者大多口服降糖药但血糖仍高。

HbA1c水平升高患者的结局不佳。4年的随访显示,HbA1c每升高1%,主要心血管不良事件风险将增加25%.Freemantle说,“重要的不是你如何控制血糖,关键是血糖达标,你需要记住的是——竭尽所能地改善HbA1c”。

同时,他也提到,经历严重低血糖事件或有症状的低血糖患者在随访期的死亡风险并未增加,患者大可放心。

血糖控制和心血管疾病风险的争议


Freemantle解释说,随机临床试验中关于血糖控制和心血管事件的发现仍具有争议,因此,真实世界中对患者的非干预性、观察性研究或许可以提高更好的视角。

CREDIT试验正是这样一项研究,该试验评估了接受胰岛素治疗的2型糖尿病患者血糖控制与心血管事件的关系。

该试验于2006—2008年纳入了加拿大、日本、欧洲10国共313个中心40岁以上的2型糖尿病患者。参与患者既往1-12个月接受胰岛素治疗。要求医生每6个月更新一次患者的数据。研究的主要复合终点为非致命性卒中、心肌梗死或心血管死亡。

患者平均年龄为61岁,一半为女性,基线期中位体重指数(BMI)为28.6,平均患病年限接近10年,尽管服用3种降糖药物,但中位HbA1c仍为9.3%(四分位间距8.1%—10.7%)。接受胰岛素治疗后,患者口服药比例为双胍类(66.3%)、磺脲类(8.1%)、格列奈类(8.1%))、噻唑烷二酮类(21.2%)、α-糖苷酶抑制剂(11.1%)。

一半以上患者胰岛素治疗为单一基础胰岛素(52%),其余患者为单一预混胰岛素(23.1%)、基础胰岛素+餐时胰岛素(14.0%)、单一餐时胰岛素(7.5%))或其它胰岛素(3.4%)。胰岛素初始剂量为中位0.20 U/kg体重,按需给予。

Freemantle教授指出,患者从血糖控制中收获颇丰,第一年中位HbA1c降到了7.4%,并且在随后3年中均维持在此水平左右。随访期间,出现44例非致命性心肌梗死、57例非致命性卒中及60例心血管死亡。全因死亡患者为148例。

研究发现,HbA1c超过平均值1%,首次卒中风险增加36%,心血管死亡风险增加31%,心肌梗死风险增加5%. Freemantle指出,由于风险比的可信区间过大,心肌梗死风险尚未明显增加很可能是由于机会性所造成的。约有53.7%的患者报告1次或以上的有症状低血糖事件,6.6%的患者报告1次或以上的严重低血糖事件,但患者随访期心血管死亡或全因死亡的相对风险并未升高。

研究强化了良好血糖控制的需求


Freemantle强调说,“研究结果证实了血糖控制好的患者具有较好的心血管结局,并且发现使用胰岛素维持良好的血糖在中期内具有优势,使用低剂量胰岛素联合其它药物降低糖化血红蛋白是安全的,并且有益于降低心血管事件”。

尽管该研究并非前瞻性对照研究,但它进一步证实控制好血糖对心血管预防至关重要。

原始出处:


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=20719, encodeId=c67d20e1914, content=国真实妊娠糖尿病患病率应该在这两种方案得到的患病率之间, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:37:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643344, encodeId=3cdf164334447, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Fri Jul 18 01:26:00 CST 2014, time=2014-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10469, encodeId=e91e10469f7, content=研究不断向前推进!, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Mon Jul 14 20:43:00 CST 2014, time=2014-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264523, encodeId=42f81264523ea, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Wed Jul 09 00:26:00 CST 2014, time=2014-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272907, encodeId=c8fb12e290707, content=<a href='/topic/show?id=2f468983351' target=_blank style='color:#2F92EE;'>#血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89833, encryptionId=2f468983351, topicName=血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef84111, createdName=whlxd, createdTime=Wed Jul 09 00:26:00 CST 2014, time=2014-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581447, encodeId=a582158144e33, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5195, encryptionId=2bc1519579, topicName=CRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca216802819, createdName=HinsMax, createdTime=Wed Jul 09 00:26:00 CST 2014, time=2014-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10329, encodeId=fa7f10329e5, content=虽然不是本专业的,呵呵,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42e3105098, createdName=sunxiaofei4457, createdTime=Tue Jul 08 09:31:00 CST 2014, time=2014-07-08, status=1, ipAttribution=)]
    2015-04-11 x35042875

    国真实妊娠糖尿病患病率应该在这两种方案得到的患病率之间

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=20719, encodeId=c67d20e1914, content=国真实妊娠糖尿病患病率应该在这两种方案得到的患病率之间, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:37:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643344, encodeId=3cdf164334447, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Fri Jul 18 01:26:00 CST 2014, time=2014-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10469, encodeId=e91e10469f7, content=研究不断向前推进!, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Mon Jul 14 20:43:00 CST 2014, time=2014-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264523, encodeId=42f81264523ea, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Wed Jul 09 00:26:00 CST 2014, time=2014-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272907, encodeId=c8fb12e290707, content=<a href='/topic/show?id=2f468983351' target=_blank style='color:#2F92EE;'>#血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89833, encryptionId=2f468983351, topicName=血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef84111, createdName=whlxd, createdTime=Wed Jul 09 00:26:00 CST 2014, time=2014-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581447, encodeId=a582158144e33, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5195, encryptionId=2bc1519579, topicName=CRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca216802819, createdName=HinsMax, createdTime=Wed Jul 09 00:26:00 CST 2014, time=2014-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10329, encodeId=fa7f10329e5, content=虽然不是本专业的,呵呵,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42e3105098, createdName=sunxiaofei4457, createdTime=Tue Jul 08 09:31:00 CST 2014, time=2014-07-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=20719, encodeId=c67d20e1914, content=国真实妊娠糖尿病患病率应该在这两种方案得到的患病率之间, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:37:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643344, encodeId=3cdf164334447, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Fri Jul 18 01:26:00 CST 2014, time=2014-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10469, encodeId=e91e10469f7, content=研究不断向前推进!, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Mon Jul 14 20:43:00 CST 2014, time=2014-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264523, encodeId=42f81264523ea, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Wed Jul 09 00:26:00 CST 2014, time=2014-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272907, encodeId=c8fb12e290707, content=<a href='/topic/show?id=2f468983351' target=_blank style='color:#2F92EE;'>#血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89833, encryptionId=2f468983351, topicName=血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef84111, createdName=whlxd, createdTime=Wed Jul 09 00:26:00 CST 2014, time=2014-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581447, encodeId=a582158144e33, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5195, encryptionId=2bc1519579, topicName=CRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca216802819, createdName=HinsMax, createdTime=Wed Jul 09 00:26:00 CST 2014, time=2014-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10329, encodeId=fa7f10329e5, content=虽然不是本专业的,呵呵,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42e3105098, createdName=sunxiaofei4457, createdTime=Tue Jul 08 09:31:00 CST 2014, time=2014-07-08, status=1, ipAttribution=)]
    2014-07-14 qingfengqishi5

    研究不断向前推进!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=20719, encodeId=c67d20e1914, content=国真实妊娠糖尿病患病率应该在这两种方案得到的患病率之间, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:37:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643344, encodeId=3cdf164334447, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Fri Jul 18 01:26:00 CST 2014, time=2014-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10469, encodeId=e91e10469f7, content=研究不断向前推进!, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Mon Jul 14 20:43:00 CST 2014, time=2014-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264523, encodeId=42f81264523ea, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Wed Jul 09 00:26:00 CST 2014, time=2014-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272907, encodeId=c8fb12e290707, content=<a href='/topic/show?id=2f468983351' target=_blank style='color:#2F92EE;'>#血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89833, encryptionId=2f468983351, topicName=血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef84111, createdName=whlxd, createdTime=Wed Jul 09 00:26:00 CST 2014, time=2014-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581447, encodeId=a582158144e33, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5195, encryptionId=2bc1519579, topicName=CRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca216802819, createdName=HinsMax, createdTime=Wed Jul 09 00:26:00 CST 2014, time=2014-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10329, encodeId=fa7f10329e5, content=虽然不是本专业的,呵呵,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42e3105098, createdName=sunxiaofei4457, createdTime=Tue Jul 08 09:31:00 CST 2014, time=2014-07-08, status=1, ipAttribution=)]
    2014-07-09 般若傻瓜
  5. [GetPortalCommentsPageByObjectIdResponse(id=20719, encodeId=c67d20e1914, content=国真实妊娠糖尿病患病率应该在这两种方案得到的患病率之间, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:37:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643344, encodeId=3cdf164334447, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Fri Jul 18 01:26:00 CST 2014, time=2014-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10469, encodeId=e91e10469f7, content=研究不断向前推进!, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Mon Jul 14 20:43:00 CST 2014, time=2014-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264523, encodeId=42f81264523ea, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Wed Jul 09 00:26:00 CST 2014, time=2014-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272907, encodeId=c8fb12e290707, content=<a href='/topic/show?id=2f468983351' target=_blank style='color:#2F92EE;'>#血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89833, encryptionId=2f468983351, topicName=血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef84111, createdName=whlxd, createdTime=Wed Jul 09 00:26:00 CST 2014, time=2014-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581447, encodeId=a582158144e33, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5195, encryptionId=2bc1519579, topicName=CRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca216802819, createdName=HinsMax, createdTime=Wed Jul 09 00:26:00 CST 2014, time=2014-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10329, encodeId=fa7f10329e5, content=虽然不是本专业的,呵呵,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42e3105098, createdName=sunxiaofei4457, createdTime=Tue Jul 08 09:31:00 CST 2014, time=2014-07-08, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=20719, encodeId=c67d20e1914, content=国真实妊娠糖尿病患病率应该在这两种方案得到的患病率之间, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:37:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643344, encodeId=3cdf164334447, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Fri Jul 18 01:26:00 CST 2014, time=2014-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10469, encodeId=e91e10469f7, content=研究不断向前推进!, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Mon Jul 14 20:43:00 CST 2014, time=2014-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264523, encodeId=42f81264523ea, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Wed Jul 09 00:26:00 CST 2014, time=2014-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272907, encodeId=c8fb12e290707, content=<a href='/topic/show?id=2f468983351' target=_blank style='color:#2F92EE;'>#血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89833, encryptionId=2f468983351, topicName=血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef84111, createdName=whlxd, createdTime=Wed Jul 09 00:26:00 CST 2014, time=2014-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581447, encodeId=a582158144e33, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5195, encryptionId=2bc1519579, topicName=CRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca216802819, createdName=HinsMax, createdTime=Wed Jul 09 00:26:00 CST 2014, time=2014-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10329, encodeId=fa7f10329e5, content=虽然不是本专业的,呵呵,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42e3105098, createdName=sunxiaofei4457, createdTime=Tue Jul 08 09:31:00 CST 2014, time=2014-07-08, status=1, ipAttribution=)]
    2014-07-09 HinsMax
  7. [GetPortalCommentsPageByObjectIdResponse(id=20719, encodeId=c67d20e1914, content=国真实妊娠糖尿病患病率应该在这两种方案得到的患病率之间, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:37:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1643344, encodeId=3cdf164334447, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Fri Jul 18 01:26:00 CST 2014, time=2014-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10469, encodeId=e91e10469f7, content=研究不断向前推进!, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Mon Jul 14 20:43:00 CST 2014, time=2014-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264523, encodeId=42f81264523ea, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Wed Jul 09 00:26:00 CST 2014, time=2014-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272907, encodeId=c8fb12e290707, content=<a href='/topic/show?id=2f468983351' target=_blank style='color:#2F92EE;'>#血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89833, encryptionId=2f468983351, topicName=血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef84111, createdName=whlxd, createdTime=Wed Jul 09 00:26:00 CST 2014, time=2014-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581447, encodeId=a582158144e33, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5195, encryptionId=2bc1519579, topicName=CRE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca216802819, createdName=HinsMax, createdTime=Wed Jul 09 00:26:00 CST 2014, time=2014-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10329, encodeId=fa7f10329e5, content=虽然不是本专业的,呵呵,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42e3105098, createdName=sunxiaofei4457, createdTime=Tue Jul 08 09:31:00 CST 2014, time=2014-07-08, status=1, ipAttribution=)]
    2014-07-08 sunxiaofei4457

    虽然不是本专业的,呵呵,学习了!

    0

相关资讯

NEJM:危重症患儿的血糖控制,适度即可

英国学者研究发现,对于危重患儿,与传统血糖控制相比,强化血糖控制不但致低血糖发生率升高,且也不能显著改善主要临床预后。论文1月9日发表于《新英格兰医学杂志》。【原文下载】 该研究共纳入1369例危重患儿,将其随机分至接受强化血糖控制组(血糖靶目标为:4.0~7.0mmol/L)和传统血糖控制组(血糖靶目标为:<12.0mmol/L)。 结果显示,随机试验30天时,患儿生存且脱离机械通气的

张抒扬:急性心肌梗死的血糖控制,要避免“过山车”

急性心肌梗死患者由于应激状态致内环境的激烈变化、血液动力学改变以及患者饮食规律、活动量变化,血糖水平往往会出现显著改变。虽然有证据显示,急性心肌梗死血糖控制不佳提示预后不良,但有关心肌梗死急性期血糖控制能否获益还存在较多争议,如急性期是否需要胰岛素强化降糖等。但有一点已达成共识:对于2型糖尿病患者,无论是急性心肌梗死,还是稳定性心绞痛,严格血糖控制的获益小于严格降压、强化调脂。 心肌梗死患者入院

Diabetologia:强化血糖控制对糖尿病视网膜病变有双向影响

临床试验表明高血糖对糖尿病患者微血管并发症发生和发展有不利影响,因此,当前血糖控制中仍有糖尿病微血管并发症的基础治疗。同时,良好的血糖控制已被证明可降低新诊断2型糖尿病患者糖尿病视网膜病变的进展。然而,在病程长、而血糖控制欠佳的2型糖尿病患者中,这方面的研究数据较少。 为此,来自美国Jr VA医院的Azad教授及其团队进行了一项研究,探讨血糖控制欠佳的糖尿病患者中,强化血糖控制(INT)

AIM:含豆类的低血糖指数饮食降低心血管危险

  加拿大学者进行的研究表明, 2型糖尿病患者将豆类作为低血糖指数(GI)饮食,既能改善血糖控制,也能降低心血管危险。文章发表于10月22日出版的《内科学文献》(Arch Intern Med)杂志。   研究者将121例2型糖尿病患者随机分为2组,一组给予低GI豆类饮食(鼓励患者增加豆类摄入每天至少1杯),另一组给予全麦纤维饮食,共3个月。   结果显示,低GI

ACP指南:住院患者血糖管理强调必要与适度

近期,美国内科医师协会(ACP)发布了住院患者血糖控制指南,将住院患者的目标血糖水平适度宽松化,即随机血糖水平目标值应为7.8~11.1mmol/L,而非<7.8mmol/L;提出重症监护室患者更应注意,不要给予强化胰岛素治疗。 ACP临床政策主管AmirQaseem指出,在内科或外科住院患者中,不论患者是否合并糖尿病,血糖水平升高的现象都很常见。高血糖可导致并发症发生率和死亡率升高

Baidu
map
Baidu
map
Baidu
map